ApoB & Lipid Panel
Why we care about ApoB more than LDL-C
March 12, 2026 · by ImmortalityLab Editors · 5 min read
WH
ApoB is a better predictor of cardiovascular risk than LDL-C. Here is why, and how to act on it.
Why we are writing this
Our editorial pieces are the places where we step back from a single paper and try to say something about the state of the field as a whole. They are opinionated on purpose, but still anchored in evidence.
The short version
Longevity is real, exciting and overhyped in roughly equal measure. The job of a good editor is to tell you which parts are which. This piece is our take today - we will happily update it when better data lands.
What to read next
- Browse the full library if you want the structured view.
- Take the longevity quiz for a quick self-assessment.
- Subscribe to the newsletter below for a weekly evidence-based brief.
This article is seed editorial content for the initial build of ImmortalityLab. Over time the editors will expand it with citations and links to primary literature.